Hetty Waskin Selected Research

posaconazole

2/2024	A population pharmacokinetic model for posaconazole intravenous solution and oral powder for suspension formulations in pediatric patients with neutropenia.
9/2023	Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis.
8/2022	Hepatic safety of the antifungal triazole agent posaconazole: characterization of adverse event reports in a manufacturer's safety database.
1/2021	Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial.
9/2020	Pharmacokinetics and safety of posaconazole intravenous solution and powder for oral suspension in children with neutropenia: an open-label, sequential dose-escalation trial.
1/2020	Pharmacokinetics and Safety of Posaconazole Tablet Formulation in Chinese Participants at High Risk for Invasive Fungal Infection.
1/2019	A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia.
1/2018	A Population Pharmacokinetic Model for a Solid Oral Tablet Formulation of Posaconazole.
12/2017	Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.
12/2017	Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hetty Waskin Research Topics

Disease

7	Mycoses (Diseases, Fungus) 08/2022 - 07/2014
5	Neutropenia 02/2024 - 10/2014
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 10/2014
3	Invasive Fungal Infections 01/2020 - 10/2014
2	Body Weight (Weight, Body) 02/2024 - 01/2018
2	Aspergillosis 09/2023 - 01/2021
2	Nausea 01/2021 - 10/2014
2	Vomiting 01/2021 - 10/2014
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2017 - 10/2014
2	Chagas Disease (American Trypanosomiasis) 02/2017 - 12/2016
1	Clostridium Infections 06/2023
1	Hallucinations (Hallucination) 01/2021
1	Infections 02/2017
1	Neoplasms (Cancer) 03/2016
1	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2016
1	Injection Site Reaction 02/2015
1	Thrombophlebitis 02/2015
1	Mucositis 10/2014
1	Headache (Headaches) 08/2007
1	Dizziness (Lightheadedness) 08/2007
1	Maxillary Sinusitis 08/2007
1	Sinusitis 08/2007
1	Dyspnea (Shortness of Breath) 08/2007
1	Hypersensitivity (Allergy) 08/2007

Drug/Important Bio-Agent (IBA)

17	posaconazole FDA Link 02/2024 - 07/2014
6	TabletsIBA 02/2024 - 10/2014
4	SolutionsIBA 02/2024 - 07/2014
4	SuspensionsIBA 02/2024 - 03/2016
2	PowdersIBA 02/2024 - 09/2020
2	Voriconazole (Vfend)FDA LinkGeneric 09/2023 - 01/2021
2	TriazolesIBA 08/2022 - 01/2019
1	bezlotoxumabIBA 06/2023
1	Alkaline PhosphataseIBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Antifungal AgentsIBA 01/2019
1	benzonidazole (benznidazole)IBA 02/2017
1	DNA (Deoxyribonucleic Acid)IBA 12/2016
1	CyclodextrinsIBA 07/2014
1	garenoxacinIBA 08/2007
1	EnzymesIBA 08/2007

Therapy/Procedure

3	Therapeutics 06/2023 - 12/2016
2	Drug Therapy (Chemotherapy) 03/2016 - 10/2014
1	Salvage Therapy 08/2022
1	Hematopoietic Stem Cell Transplantation 01/2018